<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367045">
  <stage>Registered</stage>
  <submitdate>4/09/2014</submitdate>
  <approvaldate>22/09/2014</approvaldate>
  <actrnumber>ACTRN12614001016628</actrnumber>
  <trial_identification>
    <studytitle>The Effects Of Intraarticular Platelet Rich Plasma versus Steroid Injection In Meniscal Injuries- A Randomized Controlled Trial</studytitle>
    <scientifictitle>A randomised controlled trial to evaluate the effect of intraarticular platelet rich plasma injection versus intraarticular triamcinolone acetonide injection on pain relief and functional outcomes in adult males with meniscal injuries</scientifictitle>
    <utrn>nil</utrn>
    <trialacronym>nil</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Meniscal injuries</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Two intraarticular knee injection of 3 ml of platelet rich plasma will be given 2 weeks apart in total. Platelet rich plasma will be obtained from patient's own blood. 30 ml of venous blood will be taken from the patient, which will yield 3 ml of Platelet rich plasma.</interventions>
    <comparator>A single intraarticular knee injection of 80 mg of triamcinolone acetonide will be administered</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Knee pain will be assessed using Visual analogue scale (VAS)</outcome>
      <timepoint>At baseline, 4 and 12 weeks ater intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Knee injury and osteoarthritis outcome score (KOOS) will be used to assess the knee function, symptomatic improvement, pain, stiffness in knee, </outcome>
      <timepoint>At baseline, 4 and 12 weeks ater intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>patient satisfaction in YES/NO</outcome>
      <timepoint>0,4, 12 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse events including: 1. Increase in pain
                                    2. Swelling
                                    3. Difficulty in walking</outcome>
      <timepoint>0,4 12 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Age more than 18 yrs, 
knee pain lasting more than 3 months, 
History of twisting injury to knee, 
Clinical and MRI evidence of meniscal injuries</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Other Intraarticular knee injections in last 3 months</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>numbered containers</concealment>
    <sequence>random number table</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>7/07/2014</anticipatedstartdate>
    <actualstartdate>7/07/2014</actualstartdate>
    <anticipatedenddate>7/01/2015</anticipatedenddate>
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Pakistan</country>
      <state>sindh</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Combined military hospital, Panoaqil cantt</primarysponsorname>
    <primarysponsoraddress>street number 2, H-block , postcode 65120. Panoaqil cantt, District Sukkur, province Sindh, Pakistan.</primarysponsoraddress>
    <primarysponsorcountry>Pakistan</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Combined Military Hospital, Panoaqil</fundingname>
      <fundingaddress>street number 2, H-block , postcode 65120. Panoaqil cantt, District Sukkur, province Sindh, Pakistan.</fundingaddress>
      <fundingcountry>Pakistan</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This interventional study is meant to see the efficacy of platelet rich plasma therapy in meniscal injuries. As the meniscal injuries are quite common among the sportsmen and active service military personnel, which results in lingering pain and functional limitations so this study is carried out to compare the short term functional outcomes after PRP and steroid injections.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CMH Panoaqil ethics committee</ethicname>
      <ethicaddress>CMH ethics committee, street number 2, H-block , postcode 65120. Panoaqil city, District Sukkur, province Sindh, Pakistan.</ethicaddress>
      <ethicapprovaldate>2/06/2014</ethicapprovaldate>
      <hrec>09/PNL-HEC/2014</hrec>
      <ethicsubmitdate>24/05/2014</ethicsubmitdate>
      <ethiccountry>Pakistan</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Sarah Razaq</name>
      <address>Major Sarah Razaq, classified rehab specialist, Rehab department, Combined Military Hospital, Panoaqil cantt (65120), distt Sukkur, Sindh, Pakistan</address>
      <phone>+923336123022</phone>
      <fax />
      <email>docsr@hotmail.com</email>
      <country>Pakistan</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Sarah Razaq</name>
      <address>Major Sarah Razaq, classified rehab specialist, Rehab department, Combined Military Hospital, Panoaqil cantt (65120), distt Sukkur, Sindh, Pakistan</address>
      <phone>+923336123022</phone>
      <fax />
      <email>docsr@hotmail.com</email>
      <country>Pakistan</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Sarah Razaq</name>
      <address>Major Sarah Razaq, classified rehab specialist, Rehab department, Combined Military Hospital, Panoaqil cantt (65120), distt Sukkur, Sindh, Pakistan</address>
      <phone>+923336123022</phone>
      <fax />
      <email>docsr@hotmail.com</email>
      <country>Pakistan</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>